Rocket


Overview
Financials
News + Filings
Key Docs
Transactions
Ownership
Insiders

 
 

Tango Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-05-22Dec-31-21Dec-05-21Dec-31-20Dec-31-19
Revenues24.924.937.037.07.724.6
            Revenue growth-32.9%-32.9%383.8% -68.9% 
Cost of goods sold0.0135.90.095.20.00.0
Gross profit24.9-111.137.0-58.27.724.6
            Gross margin100.0%-446.8%100.0%-157.1%100.0%100.0%
Selling, general and administrative135.9 95.2 59.9 
Research and development     32.3
General and administrative 30.0 17.6 7.5
EBIT-108.8-111.1-57.7-58.2-52.0-15.2
            EBIT margin-437.6%-446.8%-155.7%-157.1%-679.1%-61.5%
Pre-tax income-108.1-108.1-57.9-57.9-52.0-14.1
Income taxes0.10.10.30.30.00.0
            Tax rate    0.0%0.0%
Net income-108.2-108.2-58.2-58.2-52.0-14.1
            Net margin-435.1%-435.1%-157.2%-157.2%-678.8%-57.2%
 
Diluted EPS($1.23)($1.23)($0.94)($0.94)($1.63)($1.57)
Shares outstanding (diluted)87.887.862.162.131.99.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy